IP Library Granted Patent US 7,763,710
Granted Patent B2
US 7,763,710 · App. 12/236,731 · Granted Jul 27, 2010

ALS-specific peptide composition

Assignee: Amorfix Life Sciences Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,763,710
App. No.
12/236,731
Granted
Jul 27, 2010
Kind
B2
Abstract

The invention relates to a composition for eliciting an immune response in an animal to produce an antibody that binds selectively to an amyotrophic lateral sclerosis (ALS)-specific epitope.

Claims (4)

1. A composition for eliciting an immune response in an animal to produce an antibody that binds selectively to an amyotrophic lateral sclerosis (ALS)-specific epitope, the composition comprising an effective amount of the isolated ALS-specific epitope in admixture with a suitable diluent or carrier, wherein the ALS-specific epitope is an isolated peptide consisting of the amino acid sequence NPLSRKHGGPKDEE (SEQ ID NO:2).

2. The composition of claim 1 , further comprising an adjuvant.

3. The composition of claim 2 , wherein the epitope is conjugated to a molecule that enhances immunogenicity of the epitope.

4. The composition of claim 3 , wherein the molecule comprises keyhole limpet hemocyanin.

Assignments (2)
CHANGE OF NAME Recorded Oct 13, 2015
From: AMORFIX LIFE SCIENCES LTD.
To: PROMIS NEUROSCIENCES INC.
Reel/Frame 036842/0185 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2008
From: CASHMAN, NEIL; LEHTO, MARTY
To: AMORFIX LIFE SCIENCES LTD.
Reel/Frame 021970/0128 →
Continuity (5)
Division 1136760900 · Mar 3, 2006
Continuation In Part PCTCA200400150300 · Aug 20, 2004
Provisional Application 6049638100 · Aug 20, 2003
Provisional Application 6049736200 · Aug 21, 2003
Related Publication 20090098151A1 · Apr 16, 2009